Vesicare - Drug Details
๐Ÿ“Š Estimates Vesicare Dialyzability By Different_Modalities

Vesicare

Complete Drug Information

Drug Name
Vesicare
Trade Names
Vesicare, Vesicare LS
Pregnancy Category
AU: B3
Bioavailability
90%
Routes of Administration
Oral
Protein Binding
98%%
Metabolism
CYP3A4
Elimination
45 to 68 hours
Excretion
Kidney (69.2%) and fecal (22.5%)
Formula
C23H26N2O2
Molar Mass
362.473
Volume of Distribution
C23H26N2O2

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.